drug
as of 2026-07-01Zicronapine
at a glance
small molecule
Pre-approval / investigational in the US
Developed by H. Lundbeck A/S
3 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
3
Safety and Efficacy of Zicronapine in Patients With Schizophrenia
NCT01295372Phase 3Completed
Efficacy of Lu 31-130 in Patients With Schizophrenia
NCT00770744Phase 2Completed
Efficacy of Lu 31-130 in Patients With Schizophrenia
NCT00768326Phase 2Completed
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
company
trial
indication
indication
indication